Protagonist Therapeutics, Inc. (PTGX)
144.07
+1.07
(+0.75%)
USD |
NASDAQ |
Sep 21, 12:17
Protagonist Therapeutics Market Cap : 9.317B for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 9.248B |
| September 17, 2026 | 9.293B |
| September 16, 2026 | 9.238B |
| September 15, 2026 | 9.274B |
| September 14, 2026 | 9.557B |
| September 11, 2026 | 9.583B |
| September 10, 2026 | 9.388B |
| September 09, 2026 | 9.383B |
| September 08, 2026 | 9.438B |
| September 04, 2026 | 9.424B |
| September 03, 2026 | 9.623B |
| September 02, 2026 | 9.447B |
| September 01, 2026 | 9.474B |
| August 31, 2026 | 9.555B |
| August 28, 2026 | 9.334B |
| August 27, 2026 | 9.668B |
| August 26, 2026 | 9.798B |
| August 25, 2026 | 9.739B |
| August 24, 2026 | 10.01B |
| August 21, 2026 | 9.980B |
| August 20, 2026 | 9.745B |
| August 19, 2026 | 10.02B |
| August 18, 2026 | 10.18B |
| August 17, 2026 | 10.26B |
| August 14, 2026 | 10.03B |
| Date | Value |
|---|---|
| August 13, 2026 | 9.793B |
| August 12, 2026 | 9.831B |
| August 11, 2026 | 9.590B |
| August 10, 2026 | 9.701B |
| August 07, 2026 | 9.434B |
| August 06, 2026 | 9.454B |
| August 05, 2026 | 8.881B |
| August 04, 2026 | 8.783B |
| August 03, 2026 | 8.496B |
| July 31, 2026 | 8.776B |
| July 30, 2026 | 8.904B |
| July 29, 2026 | 8.542B |
| July 28, 2026 | 8.789B |
| July 27, 2026 | 8.707B |
| July 24, 2026 | 8.742B |
| July 23, 2026 | 8.698B |
| July 22, 2026 | 8.699B |
| July 21, 2026 | 8.883B |
| July 20, 2026 | 8.624B |
| July 17, 2026 | 9.050B |
| July 16, 2026 | 8.479B |
| July 15, 2026 | 8.700B |
| July 14, 2026 | 8.431B |
| July 13, 2026 | 8.342B |
| July 10, 2026 | 8.441B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 468.27B |
| Gilead Sciences, Inc. | 187.87B |
| Johnson & Johnson | 654.89B |
| Alnylam Pharmaceuticals, Inc. | 32.83B |
| BioMarin Pharmaceutical, Inc. | 12.43B |
Market Cap Related Metrics
| PE Ratio | 138.93 |
| PS Ratio | 34.40 |
| PEG Ratio | 3.050 |
| Price to Book Value | 11.07 |
| Price to Free Cash Flow | 74.28 |
| Price | 144.07 |
| Earnings Yield | 0.72% |
| PEGY Ratio | 3.050 |
| Operating PE Ratio | 166.25 |
| Normalized PE Ratio | 138.92 |